HB 139 Pharmacies; prohibit drug manufacturer and wholesalers from preventing a licensed pharmacy from acquiring drugs from entities that participate in a particular federal drug discount program Sponsor Todd Jones (R–Forsyth)
Status: In House Health
Would maintain the status quo of the current 340B arrangement with hospitals and contracted pharmacies. This bill would allow legal remedies if a pharmaceutical manufacturer or wholesaler tries to deny, restrict, prohibit, or prevent a licensed pharmacy from fulfilling their contractual arrangement
HB 291 Health; certification of community health workers; provide Sponsor Darlene Taylor (R-Thomasville)
Status: Passed House 168-4; In the Senate Health and Human Services
This bill would create a Community Health Worker Certification Committee tasked with creating rules and standards for a Community Health Worker certification. This committee would also be tasked with establishing a process for handling complaints and revocation of such certificates.
HB 326 State Health Benefit Plan Nonopioid Coverage Parity Act; enact Sponsor Michelle Au (D – Johns Creek)
Status: Passed House Health; In House Rules
This bipartisan bill would require Georgia’s State Health Benefit Plan to cover non-opioid pain management drugs at the same level as opioid pain medications. It also prevents the plan from imposing extra restrictions, such as prior authorization or step therapy, on non-opioid alternatives unless similar restrictions exist for opioids.
HB 382 Controlled substances; Schedule I; psilocybin; revise a provision Sponsor Ron Stephens (R-Savannah)
Status: Passed House 167-0
Drugs containing a synthetic version of psilocybin and approved by the Food and Drug Administration would not be defined as Psilocybin. This would allow for use in treatment of mental health, including PTSD, in patients. Would remove the certified technician requirements in the tech to pharmacist ratios. A pharmacist could supervise up to four pharmacy technicians but adds that a pharmacist cannot supervise more than six individuals, including interns and externs.
HB 419 Education; require possession of opioid antagonists by institutions within University System of Georgia Sponsor Lee Hawkins (R-Gainesville)
Status: Passed House 165-0; In Senate Higher Education
All colleges in the University System of Georgia will be required to have opioid antagonist and defibrillators on campus. Allows for possession of opioid antagonists by students and faculty. Provides some protection from civil liability when acting in good faith in decisions to apply or not apply an opioid antagonist. Allows for community groups and grants to fund access to antagonists.
HB 810 Insurance; require that final reimbursements to pharmacies for prescription drugs are based on certain formulas Sponsor Rick Jasperse (R-Jasper)
Status: Passed House Health; On House calendar for 3/6 but was not called for vote
Require PBMs reimburse Independent Pharmacies at NADAC plus the current Georgia Medicaid professional dispensing fee. If NADAC is not available, reimbursement must be based on WAC as of January 1, 2027, plus the same dispensing fee. Updated to define rural pharmacies as located in a county with a population under 50,000 and allows for higher rural contract reimbursement rates.
HB 968 Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide Sponsor Rick Townsend (R - Brunswick)
Status: Passed House Judiciary Non-Civil; In House Rules
This bill would add mitragynine and hydroxymitragynine to the list of Schedule I drugs and tighten purchasing restrictions making these only available at pharmacies behind the counter.
HB 973 Supplemental appropriations; State Fiscal Year July 1, 2025 - June 30, 2026 Sponsor Jon Burns (R-Newington)
Status: Conference Committee Report Adopted; Signed by the Governor.
Supplemental Budget for FY 2026. More budget documents can be found
here.
HB 974 General appropriations; State Fiscal Year July 1, 2026 - June 30, 2027 Sponsor Jon Burns (R - Newington)
Status: In House Appropriations; Expect Action this week
Budget for FY 2027. More budget documents can be found
here.
HB 1089 Controlled substances; ivermectin as an over-the-counter medication; provide Sponsor Karen Mathiak (R-Griffin)
Status: Passed House Health; On House Calendar for 3.6.26 but was not called for vote
This bill would allow Ivermectin to be sold over the counter. Similar bill to SB 366 whose sponsor has resigned to run for a different office.
HB 1138 Increasing Access to Contraceptives Act; enact Sponsor Beth Camp (R-Concord)
Status: Passed House 162-4; In Senate Health & Human Services
This bill would allow pharmacists, under a joint protocol agreement, to dispense self-administered hormonal contraceptives and administer injectable hormonal contraceptives without a patient-specific prescription. The Composite Medical Board and the Board of Pharmacy would join in a joint protocol agreement and be responsible for approving training for pharmacists, self-screening risk assessment for the patient, and other requirements.
HB 1309 Practitioners; clarify that all who dispense drugs are engaged in the practice of pharmacy and shall comply with all record keeping and other requirements Sponsor Mark Newton (R- Augusta)
Status: Passed House Health; In House Rules
This bill will explicitly require all practitioners dispensing drugs to adhere to pharmacy regulations, and grants the Georgia State Board of Pharmacy explicit authority to enforce rules and regulations governing practitioners dispensing drugs.
HB 1329 Controlled substances; Schedule I; provide certain provisions Sponsor Ron Stephens (R-Savannah)
Status: Passed House 171-0; In Senate Health and Human Services
Annual Drug update bill for over fifty drugs, Aceclidine to Zopapogene imadenovec-drba. There is added language on dispensing epinephrine nasal spray of 2mg or less OTC.
HB 1332 Georgia Buy American Medicine Act; enact Sponsor David Clark (R-Buford)
Status: Passed House Health; In House Rules
This bill would require hospitals receiving state funds to procure prescription drugs for patient treatment from American pharmaceutical manufacturers unless extreme circumstances or patient safety dictate otherwise.
HB 1344 Georgia Insurance Affordability and Claims Integrity Act; enact Sponsor Matt Reeves (R-Duluth)
Status: Passed House 166-3; In Senate Insurance & Labor
37-page bi-partisan bill raising fees and penalties that the Insurance and Fire Safety Commission may impose on entities found in violation of many code sections. If a person or entity is found to be acting as a PBM without a license or violating regulations, the violation fine would rise to $4,000 to $20,000 depending on the severity of the violation. It is currently $2,000 to $10,000.
HR 948 House Study Committee on Pharmacy Benefits Managers and Consumer Access to Prescription Medications; create Sponsor Ron Stephens (R-Savannah)
Status: Passed House Health; In House Rules
Creates a House Study Committee on PBMs. Committee members would include Chairman of the House Appropriations committee, Chairman of the House Health Committee and three other members appointed by the Speaker of the House. This study committee only requires approval by the House.
SB 33 "Georgia Hemp Farming Act"; total THC concentration of consumable hemp products; provide limits Sponsor Kay Kirkpatrick (R-Marietta)
Status: Passed Senate 50-6; In House Agriculture and Consumer Affairs
This bill would limit the total THC concentration on all consumable products to .3%. Specifically includes delta-8, delta-9, delta-10, and delta-11. It closes a loophole created by leaving off the various THC isomers.
SB 195 Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions; provide Sponsor Chuck Hufstetler (R-Rome)
Status: Passed Senate 55-0; Passed House 155-7; Back to Senate for Agree/Disagree
Bi-partisan bill allowing pharmacists to dispense PrEP and PEP treatment. Before dispensing or administering PrEP or PEP medication to a patient, a pharmacist will need to complete a training program accredited by ACPE and approved by the Georgia Board of Pharmacy. The Board of Pharmacy will need to approve the training program by January 1, 2027. The patient may present a negative HIV test taken within the previous seven days, or the pharmacist may order and administer a CLIA-waived HIV test.
SB 220 Putting Georgia's Patients First Act; enact Sponsor Matt Brass (R-Newnan)
Status: Passed Senate 38-17; Passed House Regulated Industries; In House Rules
This bill would replace “Low THC Oil” with “Medical cannabis” throughout various code sections and renaming the “Low THC Oil Patient Registry” the “Medical Cannabis Patient Registry.” Similar language to HB 227. This bill passed the Senate 38-17 with one amendment.
SB 440 Department of Public Health; provisions relative to duties or functions; modernize and update Sponsor Kay Kirkpatrick (R-Marietta)
Status: Passed Senate 55-0; Passed House Public & Community Health; In House Rules
Bipartisan code update dealing with the Department of Public Health. Removes outdated language on the Prescription Drug Monitoring Program (PDMP). The Georgia Department of Public Health has asked for these updates to remove the requirement that the department establish a PDMP Electronic Database Review Advisory Committee, charged with consulting with and advising the department on matters related to the establishment, maintenance, and operation of electronic prescription review. The Electronic Database Advisory Committee has not met since 2023 and was largely composed of DPH staff. The program will still engage partners in the development of improvements to the PDMP, but a statutorily established committee is no longer necessary per DPH.
SB 423 Government Transparency; campaign committees, independent committees, political action committees, and leadership committees from accepting contributions or donations from non-Georgia persons that exceed 50 percent of all contributions received; prohibit Sponsor Timothy Bearden (R-Carrollton)
Status: Passed Senate 33-21; Awaiting House Committee Assignment
This bill would prohibit campaigns, leadership committees, and political action committees from accepting more than fifty percent of their donations from donors out of state. (PharmPAC would be well within this limit should this bill pass)